Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:peginterferon_beta-1a
|
| gptkbp:approvalYear |
2014
|
| gptkbp:ATCCode |
gptkb:L03AB13
|
| gptkbp:dosingFrequency |
every 14 days
|
| gptkbp:drugClass |
gptkb:interferon_beta
|
| gptkbp:EMAApprovalYear |
2014
|
| gptkbp:form |
solution for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Plegridy
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Biogen
|
| gptkbp:mechanismOfAction |
immunotherapy
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
intramuscular injection
subcutaneous injection |
| gptkbp:sideEffect |
fever
headache muscle pain injection site reaction flu-like symptoms |
| gptkbp:usedFor |
multiple sclerosis
|
| gptkbp:bfsParent |
gptkb:Biogen
|
| gptkbp:bfsLayer |
5
|